{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:32:27Z","timestamp":1775233947045,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S13","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1186\/s12859-019-2858-6","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:02:36Z","timestamp":1563926556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Drug repurposing with network reinforcement"],"prefix":"10.1186","volume":"20","author":[{"given":"Yonghyun","family":"Nam","sequence":"first","affiliation":[]},{"given":"Myungjun","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Hang-Seok","family":"Chang","sequence":"additional","affiliation":[]},{"given":"Hyunjung","family":"Shin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"issue":"3","key":"2858_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11(3):191.","journal-title":"Nat Rev Drug Discov"},{"issue":"19\u201320","key":"2858_CR2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.drudis.2012.05.007","volume":"17","author":"I Khanna","year":"2012","unstructured":"Khanna I. Drug discovery in pharmaceutical industry: productivity challenges and trends. Drug Discov Today. 2012;17(19\u201320):1088\u2013102.","journal-title":"Drug Discov Today"},{"issue":"6","key":"2858_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"JP Hughes","year":"2011","unstructured":"Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol. 2011;162(6):1239\u201349.","journal-title":"Br J Pharmacol"},{"key":"2858_CR4","doi-asserted-by":"crossref","unstructured":"Barratt MJ, Frail DE. Drug repositioning: bringing new life to shelved assets and existing drugs: John Wiley & Sons; 2012.","DOI":"10.1002\/9781118274408"},{"issue":"20","key":"2858_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","volume":"338","author":"I Goldstein","year":"1998","unstructured":"Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397\u2013404.","journal-title":"N Engl J Med"},{"issue":"21","key":"2858_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","volume":"341","author":"S Singhal","year":"1999","unstructured":"Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999;341(21):1565\u201371.","journal-title":"N Engl J Med"},{"issue":"4","key":"2858_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/clpt.2013.1","volume":"93","author":"M Hurle","year":"2013","unstructured":"Hurle M, Yang L, Xie Q, Rajpal D, Sanseau P, Agarwal P. Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther. 2013;93(4):335\u201341.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"2858_CR8","doi-asserted-by":"publisher","first-page":"e1000938","DOI":"10.1371\/journal.pcbi.1000938","volume":"6","author":"RL Chang","year":"2010","unstructured":"Chang RL, Xie L, Xie L, Bourne PE, Palsson B\u00d8. Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput Biol. 2010;6(9):e1000938.","journal-title":"PLoS Comput Biol"},{"issue":"7270","key":"2858_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"MJ Keiser","year":"2009","unstructured":"Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175.","journal-title":"Nature"},{"issue":"5795","key":"2858_CR10","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet J-P, Subramanian A, Ross KN. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. science. 2006;313(5795):1929\u201335.","journal-title":"science"},{"issue":"5886","key":"2858_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.1158140","volume":"321","author":"M Campillos","year":"2008","unstructured":"Campillos M, Kuhn M, Gavin A-C, Jensen LJ, Bork P. Drug target identification using side-effect similarity. Science. 2008;321(5886):263\u20136.","journal-title":"Science"},{"issue":"5","key":"2858_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/clpt.2009.103","volume":"86","author":"AP Chiang","year":"2009","unstructured":"Chiang AP, Butte AJ. Systematic evaluation of drug\u2013disease relationships to identify leads for novel drug uses. Clin Pharmacol Ther. 2009;86(5):507\u201310.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"2858_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nbt1338","volume":"25","author":"MA Yildirim","year":"2007","unstructured":"Yildirim MA, Goh K-I, Cusick ME, Barabasi A-L, Vidal M. Drug--target network. Nat Biotechnol. 2007;25(10):1119.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2858_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/amiajnl-2013-002481","volume":"22","author":"D Kim","year":"2014","unstructured":"Kim D, Joung J-G, Sohn K-A, Shin H, Park YR, Ritchie MD, Kim JH. Knowledge boosting: a graph-based integration approach with multi-omics data and genomic knowledge for cancer clinical outcome prediction. J Am Med Inform Assoc. 2014;22(1):109\u201320.","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"2858_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12911-016-0315-2","volume":"16","author":"Y Nam","year":"2016","unstructured":"Nam Y, Kim M, Lee K, Shin H. CLASH: complementary linkage with anchoring and scoring for heterogeneous biomolecular and clinical data. BMC medical informatics and decision making. 2016;16(3):72.","journal-title":"BMC medical informatics and decision making"},{"issue":"23","key":"2858_CR16","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1093\/bioinformatics\/btm511","volume":"23","author":"H Shin","year":"2007","unstructured":"Shin H, Lisewski AM, Lichtarge O. Graph sharpening plus graph integration: a synergy that improves protein functional classification. Bioinformatics. 2007;23(23):3217\u201324.","journal-title":"Bioinformatics"},{"issue":"2","key":"2858_CR17","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1016\/j.eswa.2008.01.006","volume":"36","author":"H Shin","year":"2009","unstructured":"Shin H, Tsuda K, Sch\u00f6lkopf B. Protein functional class prediction with a combined graph. Expert Syst Appl. 2009;36(2):3284\u201392.","journal-title":"Expert Syst Appl"},{"issue":"3","key":"2858_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1517\/17425255.2.3.419","volume":"2","author":"G Lappin","year":"2006","unstructured":"Lappin G, Rowland M, Garner RC. The use of isotopes in the determination of absolute bioavailability of drugs in humans. Expert Opin Drug Metab Toxicol. 2006;2(3):419\u201327.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2858_CR19","doi-asserted-by":"publisher","first-page":"e3556","DOI":"10.1136\/bmj.e3556","volume":"344","author":"A Burns","year":"2012","unstructured":"Burns A. The benefits of early diagnosis of dementia. Bmj. 2012;344:e3556.","journal-title":"Bmj"},{"issue":"4","key":"2858_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/fampra\/cmg407","volume":"20","author":"S Iliffe","year":"2003","unstructured":"Iliffe S, Manthorpe J, Eden A. Sooner or later? Issues in the early diagnosis of dementia in general practice: a qualitative study. Fam Pract. 2003;20(4):376\u201381.","journal-title":"Fam Pract"},{"issue":"3","key":"2858_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000086680","volume":"25","author":"U Guehne","year":"2005","unstructured":"Guehne U, Riedel-Heller S, Angermeyer MC. Mortality in dementia. Neuroepidemiology. 2005;25(3):153\u201362.","journal-title":"Neuroepidemiology"},{"issue":"11","key":"2858_CR22","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1586\/ern.11.155","volume":"11","author":"S Karantzoulis","year":"2011","unstructured":"Karantzoulis S, Galvin JE, Braak S, Mckhann MK, Jack S, Hodges B. Distinguishing Alzheimer\u2019s disease from other major forms of dementia. Expert Rev Neurother. 2011;11(11):1579\u201391.","journal-title":"Expert Rev Neurother"},{"key":"2858_CR23","first-page":"892","volume-title":"Semi-supervised learning. Encyclopedia of machine learning","author":"X Zhu","year":"2010","unstructured":"Zhu X. Semi-supervised learning. Encyclopedia of machine learning; 2010. p. 892\u20137."}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2858-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-019-2858-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2858-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T03:19:52Z","timestamp":1610594392000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-019-2858-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":23,"journal-issue":{"issue":"S13","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2858"],"URL":"https:\/\/doi.org\/10.1186\/s12859-019-2858-6","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"24 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"383"}}